Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
P1101 Rapid Titration in Japanese PV Patients
NCT06002490Phase 3Completed
- Sponsor
- PharmaEssentia
- Start
- Oct 2023
- Primary completion
- Jul 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of ropeginterferon alfa-2b in polycythemia vera (PV), sponsored by PharmaEssentia. Started Oct 2023; status: completed.
02
Drugs
ropeginterferon alfa-2b
03
Conditions
polycythemia vera (PV)
Beyond the preview
Go deeper on NCT06002490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06002490.